OFAC sanctioned the Argentina-based Goldpharma Drug Trafficking and Money Laundering Organization ("Goldpharma DTO/MLO"), identifying the entity as a "significant foreign narcotics trafficker" pursuant to the Foreign Narcotics Kingpin Designation Act. OFAC also designated eight Argentine nationals for their role in the Goldpharma DTO/MLO, along with nine entities in Argentina, Colombia, Canada, the United Kingdom and the Netherlands.
According to OFAC, Goldpharma DTO/MLO operates a network of online pharmacy websites, which sell narcotics to customers without a prescription. OFAC asserted that Goldpharma DTO/MLO sells the majority of its illicit opioids to customers located in the U.S.
As a result of this action, all property and interests in property of the designated individuals and entities in the U.S., or in the possession or control of U.S. persons, must be blocked and reported to OFAC. In addition, OFAC regulations generally forbid all dealings by U.S. persons, and all transactions that occur within or transiting the U.S., that involve the property or interests in property of blocked individuals or entities.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
